The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms
The upcoming 5th edition of the World Health Organization (WHO) Classification of
Haematolymphoid Tumours is part of an effort to hierarchically catalogue human cancers …
Haematolymphoid Tumours is part of an effort to hierarchically catalogue human cancers …
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
The classification of myeloid neoplasms and acute leukemias was last updated in 2016
within a collaboration between the World Health Organization (WHO), the Society for …
within a collaboration between the World Health Organization (WHO), the Society for …
The International Consensus Classification of myelodysplastic syndromes and related entities
Abstract The International Consensus Classification (ICC) of myeloid neoplasms and acute
leukemia has updated the classification of myelodysplastic syndromes (MDSs) and placed …
leukemia has updated the classification of myelodysplastic syndromes (MDSs) and placed …
Advances in myelodysplastic/myeloproliferative neoplasms
S Prakash, DA Arber, C Bueso-Ramos, RP Hasserjian… - Virchows Archiv, 2023 - Springer
The myelodysplastic syndrome/myeloproliferative neoplasms (MDS/MPN) category includes
a heterogeneous group of diseases characterized by the co-occurrence of clinical and …
a heterogeneous group of diseases characterized by the co-occurrence of clinical and …
CNL and aCML should be considered as a single entity based on molecular profiles and outcomes
G Carreño-Tarragona, A Álvarez-Larrán… - Blood …, 2023 - ashpublications.org
Chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) are rare
myeloid disorders that are challenging with regard to diagnosis and clinical management …
myeloid disorders that are challenging with regard to diagnosis and clinical management …
Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum
X Calvo, D Roman-Bravo, N Garcia-Gisbert… - Blood …, 2022 - ashpublications.org
Patients with oligomonocytic chronic myelomonocytic leukemia (OM-CMML) are currently
classified according to the 2017 World Health Organization myelodysplastic syndromes …
classified according to the 2017 World Health Organization myelodysplastic syndromes …
Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemia
N Garcia-Gisbert, L Arenillas, D Roman-Bravo… - Leukemia, 2022 - nature.com
Methods Samples were collected from 284 patients: 54 CMML, 42 OM-CMML, 76 MDS, 107
Ph-negative myeloproliferative neoplasms (MPN) and 5 MDS/MPN with ring sideroblasts …
Ph-negative myeloproliferative neoplasms (MPN) and 5 MDS/MPN with ring sideroblasts …
Genetic aspects of myelodysplastic/myeloproliferative neoplasms
Simple Summary Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) are clonal
myeloid neoplasms characterized, at the time of their presentation, by the simultaneous …
myeloid neoplasms characterized, at the time of their presentation, by the simultaneous …
The fifth edition of the World Health Organization Classification and the International Consensus Classification of myeloid neoplasms: evolving guidelines in the …
G Zheng, P Li, X Zhang, Z Pan - Current Opinion in Hematology, 2023 - journals.lww.com
The fifth edition of the World Health Organization Classific... : Current Opinion in Hematology
The fifth edition of the World Health Organization Classification and the International Consensus …
The fifth edition of the World Health Organization Classification and the International Consensus …
[HTML][HTML] Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi …
R Kanagal-Shamanna, A Orazi, RP Hasserjian… - Modern Pathology, 2022 - Elsevier
Classification of myeloid neoplasms with isolated isochromosome i (17q)[17p deletion with
inherent monoallelic TP53 loss plus 17q duplication] is controversial. Most cases fall within …
inherent monoallelic TP53 loss plus 17q duplication] is controversial. Most cases fall within …